向瘤抑制剂p53用于器官纤维化治疗
Yi-Ni Bao1, Qiao Yang1, Xin-Lei Shen1
1School of Pharmacy, Zhejiang Chinese Medical University, No. 548 Binwen Road, Hangzhou, Zhejiang, 310053, China.
Cell death & disease
|May 14, 2024
概括
瘤抑制剂p53 (p53) 通过促进关键细胞过程而加剧纤维化. 向p53为预防和治疗器官纤维化提供了一个有希望的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
- 分子医学是分子医学.
背景情况:
- 纤维化涉及异常的细胞外基质沉积,导致慢性疾病中的器官功能障碍.
- 瘤抑制剂p53 (p53) 影响细胞增殖,细胞亡,衰老和新陈代谢.
- p53涉及诸如上皮层-介质细胞过渡 (EMT),亡和衰老等过程,这些过程与纤维化有关.
研究的目的:
- 审查p53.3的背景和机制.
- 为了研究纤维化的病原性.
- 讨论p53在,肝,肺和心脏纤维化中的作用.
主要方法:
- 对p53和纤维化现有研究的文献综述.
- 对将p53与纤维化过程联系起来的分子机制的分析.
- 在多个器官中检查p53在纤维化中的参与.
主要成果:
- p53在加重纤维化过程中发挥着关键作用,包括EMT,亡和衰老.
- 这些p53介导的过程与纤维菌性疾病的病原发生密切相关.
- 该审查巩固了p53在各种纤维状况中的功能证据.
结论:
- 准p53为器官纤维化提供了一个有希望的治疗途径.
- 调节p53活性可能是预防和治疗纤维化疾病的关键.
- 对于纤维状况,需要对p53向疗法的进一步研究.
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K